| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/25/2010 | US20100048863 Growth factor which acts through erb b-4 rtk |
| 02/25/2010 | US20100048735 Polyaminoacids functionalized wtih alpha-tocopherol, and uses thereof, especially therapeutic uses |
| 02/25/2010 | US20100048542 Methods and compositions for treating primary and secondary tumors of the central nervous system (cns) |
| 02/25/2010 | US20100048489 Stable Solid Formulation of A GC-C Receptor Agonist Polypeptide Suitable for Oral Administration |
| 02/25/2010 | US20100048488 Immunomodulatory peptides |
| 02/25/2010 | US20100048487 Novel cell penetrating peptide |
| 02/25/2010 | US20100048486 Use of Soluble Fgl2 As An Immunosuppressant |
| 02/25/2010 | US20100048485 Substrates of n-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate |
| 02/25/2010 | US20100048484 Methods for treating diabetic wounds |
| 02/25/2010 | US20100048483 Polymeric benzyl carbonate-derivatives |
| 02/25/2010 | US20100048482 Compositions and methods for modulating epsilon protein kinase c-mediated cytoprotection |
| 02/25/2010 | US20100048481 Controlled Release Composition |
| 02/25/2010 | US20100048480 Production of anti-microbial peptides |
| 02/25/2010 | US20100048479 Adrenal grk2 activity as a therapeutic target for heart failure |
| 02/25/2010 | US20100048478 Fn14/trail fusion proteins |
| 02/25/2010 | US20100048477 Method for prevention of platelet aggregation employing an rgd-enriched gelatine-like proteins |
| 02/25/2010 | US20100048476 Novel use of bacteriocin derived from enterococcus faecalis sl-5 |
| 02/25/2010 | US20100048475 Method of Treating Dyspnea Associated with Acute Heart Failure |
| 02/25/2010 | US20100048474 Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating nf-kappabeta or supressing nf-kappabeta-mediated actions |
| 02/25/2010 | US20100048473 Modified Protein Polymers |
| 02/25/2010 | US20100048472 Albumin Fusion Proteins |
| 02/25/2010 | US20100048471 Angiogenesis inhibitor comprising meteorin as an active ingredient |
| 02/25/2010 | US20100048470 Immunotoxins for the treatment of diseases related to cmv infection |
| 02/25/2010 | US20100048469 Antimicrobial peptides |
| 02/25/2010 | US20100048468 Glp-1 compounds |
| 02/25/2010 | US20100048467 Cystine-Knot Fold Cytokine |
| 02/25/2010 | US20100048466 Compositions, Reagents and Kits for and Methods of Diagnosing, Monitoring and Treating Hormonal Imbalance |
| 02/25/2010 | US20100048465 Peptide mimics of melanocyte stimulating hormone |
| 02/25/2010 | US20100048464 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same |
| 02/25/2010 | US20100048463 Template-fixed peptidomimetics |
| 02/25/2010 | US20100048462 Truncated pth peptides with a cyclic conformation |
| 02/25/2010 | US20100048461 Methods of use of trk receptor modulators |
| 02/25/2010 | US20100048460 Selective vpac2 receptor peptide agonists |
| 02/25/2010 | US20100048459 Lantibiotic biosynthetic gene clusters from a. garbadinensis and a. liguriae |
| 02/25/2010 | US20100048458 Tribonectins |
| 02/25/2010 | US20100048457 Glycoprotein for treating chronic obstructive pulmonary diseases |
| 02/25/2010 | US20100048456 Glycopegylation methods and proteins/peptides produced by the methods |
| 02/25/2010 | US20100048455 Formulations For Therapeutic Administration Of Thyroid Stimulating Hormone (TSH) |
| 02/25/2010 | US20100048454 Antidiabetic oral insulin-biguanide combination |
| 02/25/2010 | US20100048453 Oxazole and thiazole ppar modulator |
| 02/25/2010 | US20100048452 Injectable Sustained-Release Formulation Of Active Principles, And Process For The Preparation Thereof |
| 02/25/2010 | US20100048451 Novel spill-resistant formulations comprising hydrocolloidal polymers |
| 02/25/2010 | US20100048450 Sumoylation Control Agent and Uses Thereof |
| 02/25/2010 | US20100047846 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 02/25/2010 | US20100047838 Yeast genes that affect viral replication |
| 02/25/2010 | US20100047823 Polypeptides |
| 02/25/2010 | US20100047818 Diagnosis of carcinomas |
| 02/25/2010 | US20100047809 Pca3, pca3 genes, and methods of use |
| 02/25/2010 | US20100047369 Anti-tumor drug, medicament, composition, and use thereof |
| 02/25/2010 | US20100047367 Compounds and methods for their use |
| 02/25/2010 | US20100047360 Use Of Polyamines In The Treatment Of Psoriasis |
| 02/25/2010 | US20100047358 Food protein and charged emulsifier interaction |
| 02/25/2010 | US20100047352 Compositions and methods for treating excessive bleeding |
| 02/25/2010 | US20100047350 Osteogenic compositions containing a coloring agent |
| 02/25/2010 | US20100047335 Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof |
| 02/25/2010 | US20100047333 Modified Peptides and Their Use for the Treatment of Autoimmune Diseases |
| 02/25/2010 | US20100047330 Treatment for dark adaptation |
| 02/25/2010 | US20100047315 protective coating, spray coating; drug delivery; cardiovascular disorders |
| 02/25/2010 | US20100047314 Folinic acid derivatives for promoting bone growth |
| 02/25/2010 | US20100047309 Graft collar and scaffold apparatuses for musculoskeletal tissue engineering and related methods |
| 02/25/2010 | US20100047305 Extracellular Matrix Compositions |
| 02/25/2010 | US20100047299 Use of gdf-5 for the improvement or maintenance of dermal appearance |
| 02/25/2010 | US20100047292 Methods of processing microparticles and compositions produced thereby |
| 02/25/2010 | US20100047284 Method for reducing spasms comprising treatment with an agent that elevates the level of one or more cyclic nucleotides in the muscle |
| 02/25/2010 | US20100047275 Peptide sequences and compositions |
| 02/25/2010 | US20100047271 Vaccine compositions |
| 02/25/2010 | US20100047270 Use of plant cell membrane for the treatment of obesity |
| 02/25/2010 | US20100047267 Staphylococcus aureus proteins and nucleic acids |
| 02/25/2010 | US20100047265 Active antiangiogenic therapy |
| 02/25/2010 | US20100047263 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto |
| 02/25/2010 | US20100047259 Follistatin domain containing proteins |
| 02/25/2010 | US20100047248 Methods of processing compositions containing microparticles |
| 02/25/2010 | US20100047246 Methods and Compositions for Treating Vascular Disease |
| 02/25/2010 | US20100047236 Antibody variants |
| 02/25/2010 | US20100047235 Novel regimens for treating diseases and disorders |
| 02/25/2010 | US20100047233 Treatment of post-menopausal and post-hysterectomy mediated cognitive disorders |
| 02/25/2010 | US20100047229 Purified recombinant batroxobin with high specific activity |
| 02/25/2010 | US20100047228 Recombinantly modified plasmin |
| 02/25/2010 | US20100047227 Novel anticancer cathepsin formulations and anticancer agent for use in combined anticancer therapy |
| 02/25/2010 | US20100047226 Compositions and methods for inhibiting tumor cell growth |
| 02/25/2010 | US20100047225 Oligosaccharides comprising an aminooxy group and conjugates thereof |
| 02/25/2010 | US20100047224 Biosilica-Adhesive Protein Nanocomposite Materials: Synthesis and Application in Dentistry |
| 02/25/2010 | US20100047223 Pharmanutrient Composition(s) and System(s) for Individualized, Responsive Dosing Regimens |
| 02/25/2010 | US20100047222 Nucleic acids and polypeptides of C1 bacteriophage and uses thereof |
| 02/25/2010 | US20100047221 Compositions comprising pyruvate alkyl esters and uses thereof |
| 02/25/2010 | US20100047215 Stem cell targeting methods |
| 02/25/2010 | US20100047210 Systems and Methods for Positioning of Needles and Other Devices Within Body Tissue |
| 02/25/2010 | US20100047208 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof |
| 02/25/2010 | US20100047207 Therapeutic Composition To Improve The Effect Of The Therapy With Anti-Epidermal Growth Factor Receptor Antibodies |
| 02/25/2010 | US20100047206 Powdery composition for nasal administration |
| 02/25/2010 | US20100047205 Vaccine immunotherapy |
| 02/25/2010 | US20100047204 Use of organic compounds |
| 02/25/2010 | US20100047196 Novel microstructural protein preparations containing adsorbed biologically active substances and their application in medicine and cosmetics |
| 02/25/2010 | US20100047188 Modulation of toll-like receptor 8 expression by antisense oligonucleotides |
| 02/25/2010 | US20100047186 Peptides and Their Use |
| 02/25/2010 | US20100047179 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 02/25/2010 | US20100047178 Perylenequinone derivatives and uses thereof |
| 02/25/2010 | US20100047175 Sincalide Formulations |
| 02/25/2010 | US20100047170 Peptide Prodrugs |
| 02/25/2010 | US20100047169 NK Cell Receptor Conjugates for Treating Malignancies |